Erythropoiesis-stimulating agents: benefits and risks in supportive care of cancer

por Melosky, B.L.
Publicado 2008

Retrospective practice review of treatment of metastatic non-small-cell lung cancer with second-line erlotinib

por Melosky, B., Agulnik, J., Assi, H.
Publicado 2008

Canadian supportive care recommendations for the management of anemia in patients with cancer

por Mikhael, J., Melosky, B., Cripps, C., Rayson, D., Kouroukis, C.T.
Publicado 2007

Management of skin rash during egfr-targeted monoclonal antibody treatment for gastrointestinal malignancies: Canadian recommendations

por Melosky, B., Burkes, R., Rayson, D., Alcindor, T., Shear, N., Lacouture, M.
Publicado 2009

The role of the epidermal growth factor receptor tyrosine kinase inhibitors as therapy for advanced, metastatic, and recurrent non-small-cell lung cancer: a Canadian national conse...

por Ellis, P.M., Morzycki, W., Melosky, B., Butts, C., Hirsh, V., Krasnoshtein, F., Murray, N., Shepherd, F.A., Soulieres, D., Tsao, M.S., Goss, G.
Publicado 2009